Ftse Mib
32.665,21
-2,81%
DAX
18.002,02
-1,43%
S&P 500
5.431,60
-0,04%
NASDAQ
17.688,88
0,12%
Bitcoin
66.198,21
0,01%
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NYSE Emergent Biosolutions Inc (EBS) Emergent Biosolutions Inc (EBS) Notizie

Emergent Biosolutions Inc

EBS
6,13
0,09 (1,49%)
15 Giu 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NYSE
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
11/6/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/6/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/6/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/6/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202422:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202415:02GLOBEEmergent BioSolutions Continues Driving Progress Against the..
04/6/202422:19EDGAR2Form 144 - Report of proposed sale of securities
31/5/202421:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/5/202413:34EDGAR2Form 8-K - Current report
29/5/202403:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/5/202403:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/5/202403:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/5/202403:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/5/202403:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/5/202403:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/5/202403:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/5/202423:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/5/202413:17GLOBEEmergent BioSolutions to Hold Virtual Annual Meeting of..
01/5/202422:57GLOBEEmergent BioSolutions Reports First Quarter 2024 Financial..
01/5/202422:10GLOBEEmergent BioSolutions Announces Strategic Operational..
01/5/202417:03GLOBEEmergent BioSolutions Releases New Survey Findings..
30/4/202423:26GLOBEEmergent BioSolutions Announces Amendment to its Existing..
22/4/202414:05GLOBEEmergent BioSolutions to Release First Quarter 2024..
01/4/202414:00GLOBEAquestive Therapeutics Strengthens Board of Directors with..
28/3/202413:15GLOBEEmergent BioSolutions Continues to Broaden Access, Awareness..
25/3/202413:05GLOBEEmergent BioSolutions Receives NAI Status for Baltimore..
08/3/202422:21EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
08/3/202402:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202422:31GLOBEEmergent BioSolutions Reports Fourth Quarter 2023 Financial..
06/3/202422:15EDGAR2Form 8-K - Current report
06/3/202412:02IHMARKETNEWSU.S. Stock Futures Gain Ahead of Economic Insights; Oil..
05/3/202400:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202400:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202400:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202413:00GLOBEEmergent BioSolutions to Release Fourth Quarter & Full Year..
28/2/202402:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202402:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202413:25EDGAR2Form 8-K - Current report
21/2/202413:00GLOBEEmergent BioSolutions Appoints Industry Leader Joseph C...
11/1/202413:41EDGAR2Form 8-K - Current report
09/1/202414:40EDGAR2Form 8-K - Current report
09/1/202413:30GLOBEEmergent BioSolutions to Present at the 42nd Annual J.P...
27/12/202312:08IHMARKETNEWSWall Street Highlights: Apple Appeals Watch Ban, Tesla to..
11/12/202323:22EDGAR2Form S-8 - Securities to be offered to employees in employee..
11/12/202313:24EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
28/11/202313:15EDGAR2Form 8-K - Current report
28/11/202312:59GLOBEEmergent BioSolutions Receives $75 Million Contract Option..
24/11/202313:30GLOBEEmergent BioSolutions Receives NYSE Notice Regarding Delayed..
24/11/202313:17EDGAR2Form 8-K - Current report
16/11/202322:11EDGAR2Form 8-K - Current report
Apertura: 6,01 Min: 5,75 Max: 6,2756
Chiusura: 6,04

La tua Cronologia

NYSE
EBS
Emergent Biosolutions
LSE
TTV
Talent
COIN
BMHETH
BlockMesh
BIT
UB78F5
Unicredit Bank
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network